Boston study suggests big savings by using MRIs to diagnose prostate cancer

Boston Business Journal Article Sep 16, 2016   AdMeTech Foundation says it can save Massachusetts more than $200 million annually by using MRIs to diagnose aggressive prostate cancer. The finding is based on a clinical trial conducted at Brigham and Women’s Hospital in partnership with AdMeTech, a Boston-based non-profit to advance diagnosis and treatment of…

Patients with low risk prostate cancer on active surveillance experience good quality of life

New York, NY, July 25, 2016 Researchers found no significant differences in health related quality of life between patients with low risk prostate cancer on active surveillance and men without the disease over 3 years of followup, according to new study in the Journal of Urology ELSEVIER HEALTH SCIENCES [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Active surveillance…

New findings concerning hereditary prostate cancer

Date: July 11, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] It is a well-known fact that men with a family history of prostate cancer run an increased risk of developing the disease. The risk for brothers of men with prostate cancer is doubled. But a doubled risk of what, exactly? Prostate cancer my be an indolent condition…

Overcoming the Limitations for Prostate Cancer Diagnosis

By: Srinivas Vourganti, MD Monday, February 29, 2016 The current standard of care for prostate cancer diagnosis typically involves an initial screening step principally utilizing serum blood testing — mainly total prostate-specific antigen (PSA) and others, such as free PSA, PSA isoforms — and a follow-up confirmatory test involving biopsy tissue sampling (systematic transrectal ultrasound…